Skip to main content
Watch Insiders

Corporate insider profile

Paul T Quinlan Insider Trades

Latest reported as General Counsel of Oruka Therapeutics, Inc. (ORKA).

Purchase filings
0
Reported companies
1
Net open-market value
-$7,435,084.56
Latest transaction
Oct 20, 2026

Affiliated corporations

Reported company relationships

ORKALatest reported

Oruka Therapeutics, Inc.

General Counsel

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Oct 20, 2026Oruka Therapeutics, Inc. (ORKA)General CounselSale9,000$78.53$706,735
Sep 21, 2026Oruka Therapeutics, Inc. (ORKA)General CounselSale10,000$93.64$936,417
Sep 15, 2026Oruka Therapeutics, Inc. (ORKA)General CounselSale1,039$95.71$99,443
Aug 14, 2026Oruka Therapeutics, Inc. (ORKA)General CounselSale52,000$108.49$5,641,407
Jun 15, 2026Oruka Therapeutics, Inc. (ORKA)General CounselSale733$69.69$51,083